Cyclic AMP/PKA-promoted apoptosis: Insights from studies of S49 lymphoma cells

Hormone and Metabolic Research

Volumn 46, Issue 12, 2014, Pages 854-862

  Insel, P A ^a   Wilderman, A ^a   Zhang, L ^a   Keshwani, M M ^a   Zambon, A C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BIM; CTLA 2; forskolin; glucocorticoids; kin

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; TUMOR PROTEIN;

ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; HUMAN; METABOLISM; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HUMANS; MODELS, BIOLOGICAL; NEOPLASM PROTEINS;

EID: 84937540139     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0034-1384519     Document Type: Review

References (78)

1. Insel P. A., Zhang L., Murray F., Yokouchi H., Zambon A. C. Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger. Acta Physiol (Oxf): 2011; 204 277 287
2. Horibata K., Harris A. W. Mouse myelomas and lymphomas in culture. Exp Cell Res: 1970; 60 61 77
3. van Daalen Wetters T., Coffino P. Cultured S49 mouse T lymphoma cells. Methods Enzymol: 1987; 151 9 19
4. Sibley C. H., Tomkins G. M. Mechanisms of steroid resistance. Cell: 1974; 2 221 227
5. Yamamoto K. R., Stampfer M. R., Tomkins G. M. Receptors from glucocorticoid-sensitive lymphoma cells and two classes of insensitive clones: physical and DNA-binding properties. Proc Nat Acad Sci U S A: 1974; 71 3901 3905
6. Insel P. A., Bourne H. R., Coffino P., Tomkins G. M. Cyclic AMP-dependent protein kinase: pivotal role in regulation of enzyme induction and growth. Science: 1975; 190 896 898
7. Hochman J., Insel P. A., Bourne H. R., Coffino P., Tomkins G. M. A structural gene mutation affecting the regulatory subunit of cyclic AMP-dependent protein kinase in mutant lymphoma cells. Proc Natl Acad Sci USA: 1975; 72 5051 5055
8. Albert D. A., Nodzenski E., Yim G., Kowalski J. Effect of cyclic AMP on the cell cycle regulation of ribonucleotide reductase M2 subunit messenger RNA concentrations in wild-type and mutant S49 T lymphoma cells. J Cell Physiol: 1990; 143 251 256
9. Insel P. A., Fenno J. Cyclic AMP-dependent protein kinase mediates a cyclic AMP-stimulated decrease in ornithine and S-adenosylmethionine decarboxylase activities. Proc Natl Acad Sci USA: 1978; 75 862 865
10. Albert D. A. The effect of cyclic-AMP on the regulation of c-myc expression in T-lymphoma cells. J Clin Invest: 1995; 95 1490 1496
11. Wajeman-Chao S. A., Lancaster S. A., Graf L. H. Jr, Chambers D. A. Mechanism of catecholamine-mediated destabilization of messenger RNA encoding Thy-1 protein in T-lineage cells. J Immunol: 1998; 161 4825 4833
12. Steinberg R. A., van Daalen Wetters T., Coffino P. Kinase-negative mutants of S49 mouse lymphoma cells carry a trans-dominant mutation affecting expression of cAMP-dependent protein kinase. Cell: 1978; 15 1351 1361
13. Orellana S. A., McKnight G. S. The S49 Kin-cell line transcribes and translates a functional mRNA coding for the catalytic subunit of cAMP-dependent protein kinase. J Biol Chem: 1990; 265 3048 3053
14. Steinberg R. A. A kinase-negative mutant of S49 mouse lymphoma cells is defective in posttranslational maturation of catalytic subunit of cyclic AMP-dependent protein kinase. Mol Cell Biol: 1991; 11 705 712
15. Keshwani M. M., Klammt C., von Daake S., Ma Y., Kornev A. P., Shoe S., Insel P. A., Taylor S. S. Cotranslational cis-phosphorylation of the COOH-terminal tail is a key priming step in the maturation of cAMP-dependent protein kinase. Proc Nat Acad Sci USA: 2012; 109 E1221 E1229
16. Lemaire I., Coffino P. Cyclic AMP-induced cytolysis in S49 cells: selection of an unresponsive deathless mutant. Cell: 1977; 11 149 155
17. Bourne H. R., Coffino P., Tomkins G. M. Selection of a variant lymphoma cell deficient in adenylate cyclase. Science: 1975; 187 750 752
18. Haga T., Ross E. M., Anderson H. J., Gilman A. G. Adenylate cyclase permanently uncoupled from hormone receptors in a novel variant of S49 mouse lymphoma cells. Proc Nat Acad Sci USA: 1977; 74 2016 2020
19. Gilman A. G. Nobel Lecture. G proteins and regulation of adenylyl cyclase. Biosci Rep: 1995; 15 65 97
20. Yan L., Herrmann V., Hofer J. K., Insel P. A. β-adrenergic receptor/cAMP-mediated signaling and apoptosis of S49 lymphoma cells. Am J Physiol Cell Physiol: 2000; 279 C1665 C1674
21. Zhang L., Insel P. A. Bcl-2 protects lymphoma cells from apoptosis but not growth arrest promoted by cAMP and dexamethasone. Am J Physiol Cell Physiol: 2001; 281 C1642 C1647
22. Zhang L., Insel P. A. The pro-apoptotic protein Bim is a convergence point for cAMP/protein kinase A- and glucocorticoid-promoted apoptosis of lymphoid cells. J Biol Chem: 2004; 279 20858 20865
23. Zhang L., Zambon A. C., Vranizan K., Pothula K., Conklin B. R., Insel P. A. Gene expression signatures of cAMP/protein kinase A (PKA)-promoted, mitochondrial-dependent apoptosis. Comparative analysis of wild-type and cAMP-deathless S49 lymphoma cells. J Biol Chem: 2008; 283 4304 4313
24. Lamb D., Steinberg R. A. Anti-proliferative effects of 8-chloro-cAMP and other cAMP analogs are unrelated to their effects of protein kinase A regulatory subunit expression. J Cell Physiol: 2002; 192 216 224
25. Zambon A. C., Zhang L., Minovitsky S., Kanter J. R., Prabhakar S., Salomonis N., Vranizan K., Dubchak I., Conklin B. R., Insel P. A. Gene expression patterns define key transcriptional events in cell-cycle regulation by cAMP and protein kinase A. Proc Natl Acad Sci USA: 2005; 102 8561 8566
26. Gillings A. S., Balmanno K., Wiggins C. M., Johnson M., Cook S. J. Apoptosis and autophagy: BIM as a mediator of tumour cell death in response to oncogene-targeted therapeutics. FEBS J: 2009; 276 6050 6062
27. Akiyama T., Tanaka S. Bim: guardian of tissue homeostasis and critical regulator of the immune system, tumorigenesis and bone biology. Arch Immunol Ther Exp (Warsz): 2011; 59 277 287
28. Weber K., Harper N., Schwabe J., Cohen G. M. BIM-mediated membrane insertion of the BAK pore domain is an essential requirement for apoptosis. Cell Rep: 2013; 5 409 420
29. Roulston A., Muller W. J., Shore G. C. BIM, PUMA and the achilles' heel of oncogene addiction. Sci Signal: 2013; 6 pe12
30. Zambon A. C., Wilderman A., Ho A., Insel P. A. Increased expression of the pro-apoptotic protein BIM, a mechanism for cAMP/protein kinase A (PKA)-induced apoptosis of immature T cells. J Biol Chem: 2011; 286 33260 33267
31. Suzuki S., Yokoyama U., Abe T., Kiyonari H., Yamashita N., Kato Y., Kurotani R., Sato M., Okumura S., Ishikawa Y. Differential roles of Epac in regulating cell death in neuronal and myocardial cells. J Biol Chem: 2010; 285 24248 24259
32. Huseby S., Gausdal G., Keen T. J., Kjærland E., Krakstad C., Myhren L., Bronstad K., Kunick C., Schwede F., Genieser H. G., Kleppe R., Doskeland S. O. Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription. Cell Death Dis: 2011; 2 e237
33. Nedvetsky P. I., Kwon S. H., Debnath J., Mostov K. E. Cyclic AMP regulates formation of mammary epithelial acini in vitro. Mol Biol Cell: 2012; 23 2973 2981
34. Lee Y. Y., Moujalled D., Doerflinger M., Gangoda L., Weston R., Rahimi A., de Alboran I., Herold M., Bouillet P., Xu Q., Gao X., Du X. J., Puthalakath H. CREB-binding protein (CBP) regulates β-adrenoceptor (β-AR)-mediated apoptosis. Cell Death Differ: 2013; 20 941 952
35. Lin D. C., Xu L., Ding L. W., Sharma A., Liu L. Z., Yang H., Tan P., Vadgama J., Karlan B. Y., Lester J., Urban N., Schummer M., Doan N., Said J. W., Sun H., Walsh M., Thomas C. J., Patel P., Yin D., Chan D., Koeffler H. P. Genomic and functional characterization of phosphodiesterase subtype 4D in human cancers. Proc Nat Acad Sci USA: 2013; 110 6109 6114
36. Moujalled D., Weston R., Anderton H., Ninnis R., Goel P., Coley A., Huang D. C., Wu L., Strasser A., Puthalakath H. Cyclic-AMP-dependent protein kinase A regulates apoptosis by stabilizing the BH3-only protein Bim. EMBO Rep: 2010; 12 77 83
37. Coley A. M., Moujalled D., Puthalakath H. The PKA paradox: is Bim the answer? Cell Cycle: 2011; 10 729 730
38. Brunet J. F., Denizot F., Golstein P. A differential molecular biology search for genes preferentially expressed in functional T lymphocytes: the CTLA genes. Immunol Rev: 1988; 103 21 36
39. Deshapriya R. M., Takeuchi A., Shirao K., Watabe S., Murakami R., Tsujimara H., Yamamoto Y. Drosophila CTLA-2-like protein (D/CTLA-2) inhibits cysteine proteinase 1 (CP1), a cathepsin L-like enzyme. Zoolog Sci: 2007; 24 21 30
40. Yamamoto Y., Kurata M., Watabe S., Murakami R., Takahashi S. Y. Novel cysteine proteinase inhibitors homologous to the proregions of cysteine proteinases. Curr Protein Pept Sci: 2002; 3 231 238
41. Zhang L., Yun H., Murray F., Lu R., Wang L., Hook V., Insel P. A. Cytotoxic T lymphocyte antigen-2 alpha induces apoptosis of murine T-lymphoma cells and cardiac fibroblasts and is regulated by cAMP/PKA. Cell Signal: 2011; 23 1611 1616
42. Denizot F., Brunet J. F., Roustan P., Harper K., Suzan M., Luciani M. F., Mattei M. G., Golstein P. Novel structures CTLA-2 alpha and CTLA-2 beta expressed in mouse activated T cells and mast cells and homologous to cysteine proteinase proregions. Eur J Immunol: 1989; 19 631 635
43. Delaria K., Fiorentino L., Wallace L., Tamburini P., Brownell E., Muller D. Inhibition of cathepsin L-like cysteine proteases by cytotoxic T-lymphocyte antigen-2 beta. J Biol Chem: 1994; 269 25172 25177
44. Zhang L., Murray F., Zahno A., Kanter J. R., Chou D., Suda R., Fenlon M., Rassenti L., Cottam H., Kipps T. J., Insel P. A. Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia. Proc Nat Acad Sci USA: 2008; 105 19532 19537
45. Lajevic M. D., Suleiman S., Cohen R. L., Chambers D. A. Activation of p38 mitogen-activated protein kinase by norepinephrine in T-lineage cells. Immunology: 2011; 132 197 208
46. Gu C., Ma Y. C., Benjamin J., Littman D., Chao M. V., Huang X. Y. Apoptotic signaling through the beta-adrenergic receptor. A new Gs effector pathway. J Biol Chem: 2000; 275 20726 20733
47. Wu W. W., Wang G., Insel P. A., Hsiao C. T., Zou S., Martin B., Maudsley S., Shen R. F. Discovery- and target-based protein quantification using iTRAQ and pulsed Q collision induced dissociation (PQD). J Proteomics: 2012; 75 2480 2487
48. Guo Y., Wilderman A., Zhang L., Taylor S. S., Insel P. A. Quantitative proteomics analysis of the cAMP/protein kinase A signaling pathway. Biochemistry: 2012; 51 9323 9332
49. Steinberg R. A., Coffino P. Two-dimensional gel analysis of cyclic AMP effects in cultured S49 mouse lymphoma cells: protein modification, inductions and repressions. Cell: 1979; 18 719 733
50. Steinberg R. A., Kiss Z. Basal phosphorylation of cyclic AMP-regulated phosphoproteins in intact S49 mouse lymphoma cells. Biochem J: 1985; 227 987 994
51. Chan A. S., Ng L. W., Poon L. S., Chan W. W., Wong Y. H. Dopaminergic and adrenergic toxicities on SK-N-MC human neuroblastoma cells are mediated through G protein signaling and oxidative stress. Apoptosis: 2007; 12 167 179
52. Ferretti A. C., Mattaloni S. M., Ochoa J. E., Larocca M. C., Favre C. Protein kinase A signals apoptotic activation in glucose-deprived hepatocytes: participation of reactive oxygen species. Apoptosis: 2012; 17 475 491
53. Branco A. F., Sampaio S. F., Wieckowski M. R., Sardão V. A., Oliveira PJ. Mitochondrial disruption occurs downstream from β-adrenergic overactivation by isoproterenol in differentiated, but not undifferentiated H9c2 cardiomyoblasts: differential activation of stress and survival pathways. Int J Biochem Cell Biol: 2013; 45 2379 2391
54. Rahimi A., Lee Y. Y., Abdella H., Doerflinger M., Gangoda L., Srivastava R., Xiao K., Ekert P. G., Puthalaskath H. Role of p53 in cAMP/PKA pathway mediated apoptosis. Apoptosis: 2013; 18 1492 1499
55. Lerner A., Epstein PM. Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies. Biochem J: 2006; 393 21 41
56. Murray F., Insel PA. Targeting cAMP in chronic lymphocytic leukemia: a pathway-dependent approach for the treatment of leukemia and lymphoma. Expert Opin Ther Targets: 2013; 17 937 949
57. Lu D., Aroonsakool N., Yokoyama U., Patel H. H., Insel P. A. Increase in cellular cAMP concentrations reverses the profibrogenic phenotype of cardiac myofibroblasts: a novel therapeutic approach for cardiac fibrosis. Mol Pharmacol: 2013; 84 787 793
58. Oikawa M., Wu M., Lim S., Knight W. E., Miller C. L., Cai Y., Lu Y., Blaxall B. C., Takeishi Y., Abe J., Yan C. Cyclic nucleotide phosphodiesterease 3A1 protects the heart against ischemia-reperfusion injury. J Mol Cell Cardiol: 2013; 64 11 19
59. Zhang X., Szeto C., Gao E., Tang M., Jin J., Fu Q., Makarewich C., Ai X., Li Y., Tang A., Wang J., Gao H., Wang F., Ge X. J., Kunapuli S. P., Zhou L., Zeng C., Xiang K. Y., Chen X. Cardiotoxic and cardioprotective feature of chronic β-adrenergic signaling. Circ Res: 2013; 112 498 509
60. Li G., Cong L., Gasser J., Zhao J., Chen K., Li F. Mechanisms underlying the anti-proliferative actions of adiponectin in human breast cancer cells, MCF7-dependency on the cAMP/protein kinase-A pathway. Nutr Cancer: 2011; 63 80 88
61. Ligumsky H., Wolf I., Israeli S., Haimsohn M., Ferber S., Karasik A., Kaufman B., Rubinek T. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells. Breast Cancer Res Treat: 2012; 132 449 461
62. Cao W., Ma Z., Rasenick M. M., Yeh S., Yu J. N-3 poly-unsaturated fatty acids shift estrogen signaling to inhibit human breast cancer cell growth. PLoS One: 2012; 7 e52838
63. Spina A., Di Maiolo F., Esposito A., D'Auria R., Di Gesto D., Chiosi E., Sorvillo L., Naviglio S. Integrating leptin and cAMP signalling pathways in triple-negative breast cancer cells. Front Biosci (Landmark Ed): 2013; 18 133 144
64. Yang L., Wang Y. L., Liu S., Zhang P. P., Chen Z., Liu M., Tang H. miR-181b promotes cell proliferation and reduces apoptosis by repressing the expression of adenylyl cyclase 9 (AC9) in cervical cancer cells. FEBS Lett: 2014; 588 124 130
65. Appukuttan A., Kasseckert S. A., Micoogullari M., Flacke J. P., Kumar S., Woste A., Abdallah Y., Pott L., Reusch H. P., Ladilov Y. Type 10 adenylyl cyclase mediates mitochondrial Bax translocation and apoptosis of adult rat cardiomyocytes under simulated ischaemia/reperfusion. Cardiovasc Res: 2012; 93 340 349
66. Chen Y. X., Allars M., Maiti K., Angeli G. L., Abou-Seif C., Smith R., Nicholson R. C. Factors affecting cytotrophoblast cell viability and differentiation: Evidence of a link between syncytialisation and apoptosis. Int J Biochem Cell Biol: 2011; 43 821 828
67. Arnold D. E., Gagne C., Niknejad N., McBurney M. W., Dimitroulakos J. Lovastatin induces neuronal differentiation and apoptosis of embryonal carcinoma and neuroblastoma cells: enhanced differentiation and apoptosis in combination with dbcAMP. Mol Cell Biochem: 2010; 345 1 11
68. Salma J., McDermott J. C. Suppression of a MEF2-KLF6 survival pathway by PKA signaling promotes apoptosis in embryonic hippocampal neurons. J Neurosci: 2012; 32 2790 2803
69. Villarruel E. Q., Borda E., Sterin-Borda L., Orman B. Lidocaine-induced apoptosis of gingival fibroblasts: participation of cAMP and PKC activity. Cell Biol Int: 2011; 35 783 788
70. Ku B. M., Lee Y. K., Jeong J. Y., Ryu J., Choi J., Kim J. S., Cho Y. W., Roh G. S., Kim H. J., Cho G. J., Choi W. S., Kang S. S. Caffeine inhibits cell proliferation and regulates PKA/GSK3β pathways in U87MG human glioma cells. Mol Cells: 2011; 31 275 279
71. Sugimoto N., Miwa S., Ohno-Shosaku T., Tsuchiya H., Hitomi Y., Nakamura H., Tomita K., Yachie A., Koizumi S. Activation of tumor suppressor protein PTEN and induction of apoptosis are involved in cAMP-mediated inhibition of cell number in B92 glial cells. Neurosci Lett: 2011; 497 55 59
72. Moon E. Y., Lee G. H., Lee M. S., Kim H. M., Lee J. W. Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1/Rap1 pathways. Life Sci: 2012; 90 373 380
73. Koehler J. A., Kain T., Drucker D. J. Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells. Endocrinology: 2011; 152 3362 3372
74. Follin-Arbelet V., Torgersen M. L., Naderi E. H., Misund K., Sundan A., Blomhoff H. K. Death of multiple myeloma cells induced by cAMP-signaling involves downregulation of Mcl-1 via the JAK/STAT pathway. Cancer Lett: 2013; 335 323 331
75. Park K. H., Park H. J., Shin K. S., Choi H. S., Kai M., Lee M. K. Modulation of PC12 cell viability by forskolin-induced cyclic AMP levels through ERK and JNK pathways: an implication for L-DOPA-induced cytotoxicity in nigrostriatal dopamine neurons. Toxicol Sci: 2012; 128 247 257
76. Leadsham J. E., Gourlay C. W. cAMP/PKA signaling balances respiratory activity with mitochondria dependent apoptosis via transcriptional regulation. BMC Cell Biol: 2010; 11 92
77. Loots G. G., Ovcharenko I. rVISTA 2.0: evolutionary analysis of transcription factor binding sites. Nucleic Acids Res: 2004; W217 W221
78. Gilley J., Coffer P. J., Ham J. FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol: 2003; 162 613 622